Cetuximab in combination with carboplatin and docetaxel for patients with metastatic or advanced-stage nonsmall cell lung cancer

This publication has 26 references indexed in Scilit:

• Antibody-Dependent Cellular Cytotoxicity Mediated by Cetuximab against Lung Cancer Cell Lines
  Clinical Cancer Research, 2007
• Cancer Statistics, 2007
  CA: A Cancer Journal for Clinicians, 2007
• Phase II Trial of Cetuximab in Patients With Previously Treated Non–Small-Cell Lung Cancer
  Journal of Clinical Oncology, 2006
• A randomized phase III trial of gemcitabine (G) in combination with carboplatin (C) or paclitaxel (P) versus paclitaxel plus carboplatin in advanced (Stage IIIB, IV) non-small cell lung cancer (NSCLC): Update of the Alpha Oncology trial (A1–99002L)
  Journal of Clinical Oncology, 2005
• State-of-the-art chemotherapy for advanced non-small cell lung cancer
  Seminars in Oncology, 2004
• Three-Arm Randomized Study of Two Cisplatin-Based Regimens and Paclitaxel Plus Gemcitabine in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group—EORTC 08975
  Journal of Clinical Oncology, 2003
• Targeting epidermal growth factor receptor in lung cancer
  Current Oncology Reports, 2002
• Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
  New England Journal of Medicine, 2002
• The EGFR as a target for anticancer therapy—focus on cetuximab
  European Journal Of Cancer, 2001
• Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial
  Journal of Clinical Oncology, 2001